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This study evaluated four polymorphisms located in the DC-SIGN (CD209) gene promoter region
(positions ”336, ”332 ”201 and ”139) in DNA samples from four Brazilian ethnic groups
(Caucasians, Afro-Brazilian, Asians and Amerindians) to establish the population distribution of
these single-nucleotide polymorphisms (SNPs) and correlated DC-SIGN polymorphisms and
infection in samples from human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals. To
identify CD209 SNPs, 452 bp of the CD209 promoter region were sequenced and the genotype
and allelic frequencies were evaluated. This is the first study to show genetic polymorphism in the
CD209 gene in distinct Brazilian ethnic groups with the distribution of allelic and genotypic
frequency. The results showed that ”336A and ”139A SNPs were quite common in Asians and
that the ”201T allele was not observed in Caucasians, Asians or Amerindians. No significant
differences were observed between individuals with HTLV-1 disease and asymptomatic patients.
However, the ”336A variant was more frequent in HTLV-1-infected patients [HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP), 80%; healthy asymptomatic HTLV-1
carriers, 90%] than in the control group (70%) [P50.0197, odds ratio (OR)52.511, 95%
confidence interval (CI)51.218–5.179). In addition, the ”139A allele was found to be associated
with protection against HTLV-1 infection (P50.0037, OR50.3758, 95% CI50.1954–0.7229)
when the HTLV-1-infected patients as a whole were compared with the healthy-control group.
These observations suggest that the ”139A allele may be associated with HTLV-1 infection,
although no significant association was observed among asymptomatic and HAM/TSP patients. In
conclusion, the variation observed in SNPs ”336 and ”139 indicates that this lectin may be of
crucial importance in the susceptibility/transmission of HTLV-1 infections.
INTRODUCTION
Dendritic cells (DCs) are professional antigen-processing
cells that act against invading pathogens (Banchereau &
Steinman, 1998), being important as initiators and
modulators of the immune response. DCs are efficient
stimulators of T and B cells. As invading pathogens appear,
DCs are produced in bone marrow and migrate to the
tissues, where they capture and process the antigens. DC-
SIGN [DC-specific intercellular adhesion molecule 3
(ICAM-3)-grabbing non-integrin], encoded by a member
of the CD209 gene family, is a receptor on DCs that binds
to ICAM-3, which is expressed on T cells to facilitate the
initial interaction between DCs and T cells (Soilleux et al.,
2002). Recently, Ceccaldi et al. (2006) demonstrated that
DC-SIGN is an important co-factor that facilitates the
fusion between HTLV-1-infected cells and DCs through
ICAM-dependent mechanisms. In this context, DC-SIGN 3These authors contributed equally to this work.
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Ebola virus, cytomegalovirus, dengue virus and other
agents of infectious disease (Alvarez et al., 2002; Halary
et al., 2002; Tailleux et al., 2003; Tassaneetrithep et al.,
2003). In addition, Sakuntabhai et al. (2005) demonstrated
that polymorphisms in the CD209 gene promoter region
(position 2336) affect its activity by modifying gene
transcription significantly. Therefore, variations in this
region may have an influence on the pathogenesis of
human infectious diseases.
Human T-cell lymphotropic virus type 1 (HTLV-1) was
the first retrovirus isolated from humans (Poiesz et al.,
1980). The virus has tropism for T cells and is related to
clinical disorders such as adult T-cell leukaemia/lymphoma
(Hinuma et al., 1981; Yoshida et al., 1982) and HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/
TSP) (Gessain et al., 1985; Osame et al., 1986). Other
inflammatory syndromes are also related to HTLV-1, such
as polymyositis (Morgan et al., 1989), uveitis (Mochizuki
et al., 1992) and infective dermatitis (LaGrenade et al.,
1990). Nevertheless, only 2–3% of infected individuals
develop these disorders. These distinct clinical disorders
may depend on the type and magnitude of the host
immune response to HTLV-1 antigens and the site/organ
where the inflammatory reactions occurred. Several studies
have demonstrated that genetic heterogeneity may deter-
mine the molecular basis of predisposition to HTLV-1
infection (Plancoulaine et al., 2006; Pociot et al., 1992;
Turner et al., 1997). Thus, is important to point out that
host genetic factors may contribute to disease susceptibil-
ity, although the precise mechanisms involved are not
completely understood.
On this basis, the objective of the present study was to
investigate the distribution of four single-nucleotide
polymorphisms (SNPs) located in the CD209 gene
promoter at positions 2336, 2332, 2201 and 2139 in
four distinct Brazilian ethnic groups (Caucasians, Afro-
Brazilians, Asians and Amerindians). We also compared
SNP distribution between HTLV-1-infected individuals
and a control group to determine whether the frequencies
of CD209 polymorphisms influence the susceptibility of
HTLV-1-infected individuals to developing HAM/TSP.
METHODS
Study design
Brazilian ethnic groups. Blood samples were collected from four
ethnically distinct Brazilian populations: 45 from Caucasian
individuals (46.7% males; mean age, 38.7 years), 25 from Afro-
Brazilians (60.0% males; mean age, 34.4 years), 28 from Asians
(57.1% males; mean age, 40.7 years) and 25 from Amerindians
(69.6% males; it was not possible to determine the age of the
Amerindians). The Caucasian, Afro-Brazilian and Asian groups were
selected at random from blood donors of the Regional Blood Center
of Ribeira ˜o Preto and Nu ´cleo de Haemoterapia of Franca, Brazil.
Only individuals who reported the absence of racial admixture in
their four grandparents were included in the study. The Amerindian
samples were collected from Xavante Amerindians who live in
Campina ´polis city, Mato Grosso state, Brazil.
HTLV-1-seropositive individuals. The HTLV-1-seropositive patients
studied here were detected among blood-donor candidates of the
Regional Blood Center of Ribeira ˜o Preto and among patients of the
Neurology Department of the University Hospital, Sa ˜o Paulo, Brazil.
Diagnosis of HTLV-1/2 infection was established by antibody
screening of serum/plasma samples using an enzyme immunoassay
(rp21e-enhanced EIA; Cambridge Biotech), followed by confirmation
by PCR (tax and LTR regions). The total HTLV-1 group consisted of
66 patients (62.1% females; mean age, 47.5 years), most of whom
were Caucasian (77.3%). The HTLV-1 group was classified into
healthy asymptomatic HTLV-1 carriers (HAC) and patients with
HAM/TSP. The HAC group consisted of 33 individuals (54.5%
females; mean age, 40.5 years) and the HAM/TSP group consisted of
33 patients (69.7% females; mean age, 53.2 years). Both groups were
mainly of Caucasian origin (75.8 and 78.8%, respectively). The
admixed control group consisted of 32 randomly selected blood
donors from the same geographical region as the HTLV-1-positive
individuals described above, with a mean age of 34.8 years (84.4%
males); the ethnic background was evaluated based on skin colour
and individuals were mainly Caucasians (62.5%) and African
descendants (34.4%). The study was approved by the Institutional
Ethics Committee of the University Hospital, Faculty of Medicine of
Ribeira ˜o Preto, University of Sa ˜o Paulo (process number 7639/2005)
and all subjects gave written, informed consent to participate.
DNA extraction. A 5 ml blood sample was collected into EDTA-
containing tubes and plasma was separated under aseptic conditions
by centrifugation at 900g for 10 min at 4 uC. The white-cell layer was
aspirated together with the red blood cells and placed in sterile 15 ml
polypropylene tubes. DNA was extracted from the buffy coat by using
a Super Quick Gene DNA Isolation kit (Analytical Genetic Testing
Center, CO, USA) and diluted in 200 ml ultrapure water. All samples
were quantified and diluted to 0.1 mg DNA ml
21.
Amplification reaction. For genotyping, the CD209 gene promoter
was amplified in all samples under study by using the primers 59-
CAAAAATGAGGACAGCAGCA-39 and 59-CTCCAAGGAACCAA-
GACTGC-39, which delimit the promoter region between nt 2423
and 28 (defined from GenBank accession no. NC_000019) and
amplify a fragment of 452 bp. Reactions were performed in 25 ml
mixtures containing 100 ng DNA, 1.0 U Taq DNA polymerase
(Invitrogen Life Technologies), 50 mM KCl, 20 mM Tris/HCl
(pH 8.3), 1.5 mM MgCl2, 0.2 mM each dNTP and 0.3 pmol each
primer. Thermocycling was performed in a GeneAmp PCR system
9700 (Applied Biosystems) under the following conditions: an initial
cycle at 95 uC for 5 min and 35 cycles at 95 uC for 40 s, 62 uC for 40 s
and 72 uC for 60 s, with a final extension step of 72 uC for 10 min.
The amplified products were analysed by 1% agarose gel electro-
phoresis followed by ethidium bromide staining.
DNA sequencing. Sequencing reactions were performed using PCR
primers and a DYEnamic ET dye terminator kit (GE Healthcare UK)
according to the manufacturer’s instructions. Electrophoresis was
carried out using an automated apparatus MegaBace DNA sequen-
cing system 1000 (Amersham Biosciences). The electropherograms
were analysed by using Sequence Analyser software version 1
(Amersham Biosciences). Consensus sequences were obtained and
compared by multiple alignments, using GenBank accession no.
NC_000019 as the prototype sequence.
Sequences analysis. Electropherograms were processed by using
the base-calling program Phred (Ewing & Green, 1998; Ewing et al.,
1998), resulting in the generation of files including information about
base content and base quality of each sequence. The sequences were
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Math program (http://www.phrap.org). Multiple alignments were
produced by using the POLYBAYES multiple-alignment algorithms
(Marth et al., 1999). The SNPs were detected in the highly similar
regions of multiple anchored alignments by using the PolyPhred
program (Nickerson et al., 1997). An automated pipeline was
prepared to process the above steps, integrated with a number of
in-house-developed Perl scripts.
Statistical analysis. Ethnic differences between patients and
controls were evaluated by an exact test that employed the
Metropolis algorithm to obtain an unbiased estimate of the exact P
value and its standard error by using R6C software (http://
www.marksgeneticsoftware.net/rxc.htm). This same method was used
to compare the frequencies of SNPs among the ethnic groups. Allelic
frequencies and observed heterozygosity were computed by a direct
counting method. Adherences of genotypic proportions to expecta-
tions under Hardy–Weinberg equilibrium were tested by the exact
test of Guo & Thompson (1992), employing Arlequin software
version 3.11 (Excoffier et al., 2005). GENEPOP version 3.4 software
(Raymond & Rousset, 1995a) was used to perform a pairwise exact
test of population differentiation (Raymond & Rousset, 1995b) based
on allele and genotype frequencies. The Arlequin 3.11 software was
also used to perform an exact test of population differentiation based
on haplotype frequencies.
The presence of a significant association between loci was determined
by means of a likelihood-ratio test of linkage disequilibrium (Excoffier
& Slatkin, 1998) using the Arlequin program, version 3.1 (Excoffier
et al., 2005). Given the positive association but unknown gametic
phase, the PHASE (Stephens et al., 2001) and EM (Excoffier & Slatkin,
1995) algorithms were also used to reconstruct CD209 haplotypes.
The allele, genotype and haplotype frequencies were compared by
using Fisher’s exact test implemented in GraphPad InStat 3 software,
which was also used to estimate the odds ratio (OR) and its 95%
confidence interval (CI).
RESULTS
CD209 promoter polymorphisms in the Brazilian
population
We investigated four polymorphisms located in the CD209
promoter region at positions 2336, 2332, 2201 and 2139
that are known to be associated with susceptibility/
resistance to pathogens. The allelic frequencies of these
SNPs for Brazilian ethnic groups and other populations
previously described are presented in Table 1. All loci
evaluated in the CD209 promoter region fitted the Hardy–
Weinberg equilibrium expectations for all groups.
The 2336G allele showed higher frequencies in Afro-
Brazilians (42.0%) and Caucasians (26.7%) than in Asians
(5.4%). In addition, this allele was not observed in the
Amerindian group, and the admixed control group
presented frequencies similar to those of the Caucasian
group (Table 1). SNP 2332A was present at low
frequencies in almost all ethnic groups from Brazil, except
the Amerindians. Due to its low frequency among the
groups, the control group did not present SNP 2332A
Table 1. Allelic frequencies among Brazilian ethnic groups and previously reported frequencies of the CD209
promoter polymorphisms
Ethnic group n* Allelic frequency (%) Reference
”336G ”332A ”201T ”139G
Brazilian groups
Caucasian 90 26.7 4.4 0.0 64.4 This study
Black 50 42.0 4.0 6.0 74.0 This study
Asian 56 5.4 10.7 0.0 37.5 This study
Amerindians 50 0.0 0.0 0.0 70.0 This study
Brazilian admixed control group 64 29.7 0.0 1.6 59.4 This study
Other worldwide populations
Zimbabwean 200 45.0 2.0 11.5 74.0 Boily-Larouche et al. (2007)
Sub-Saharan African 82 37.8 – – 87.8 Barreiro et al. (2006a)
South African (coloured) 1422 42.8 – – 72.1 Barreiro et al. (2007)
Caucasian Canadian 200 18.0 – 0 69.5 Boily-Larouche et al. (2007)
Caucasian European 86 20.9 – – 75.6 Barreiro et al. (2006a)
Thai 160 8.0 – 0 26.7 Sakuntabhai et al. (2005)
Asian 86 5.8 – – 33.7 Barreiro et al. (2006a)
Granada, Spain 624 21.3 – – – Nu ´n ˜ez et al. (2006)
Medellin, Colombia 598 19.1 – – – Go ´mez et al. (2006)
Pakistani 156 14.1 – – 56.4 Barreiro et al. (2006b)
Guinea Bissau 680 49.9 – – 76.0 Olesen et al. (2007)
Thailand 580 9.5 – – 28.9 Wichukchinda et al. (2007)
JapaneseD 216 3.7 – – 20.4 Koizumi et al. (2007)
*n, Number of alleles.
DHIV-1-infected Japanese haemophiliacs with the slow-progressor phenotype.
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frequencies in the Asian group (10.7%) compared with
Afro-Brazilian (4.0%) and Caucasian (4.4%) individuals.
We also analysed the 2201T/G position, which was absent
in all ethnic groups from Brazil except for the Afro-
Brazilian population (6.0%) and was present in the control
group at a frequency of 1.6%. Analysis of the 2139A/G
position showed that the allelic frequency of SNP 2139A
was higher in Asians (62.5%) than in Afro-Brazilians
(26.0%), Caucasians (35.6%) and Amerindians (30.0%).
The Brazilian control group showed frequencies similar to
those of the Caucasian group (Table 1).
An exact test of allelic frequency differentiation, performed
based on the frequencies of SNPs 2336 and 2139, did not
reveal any difference between Brazilian Caucasians and
European Caucasians (Barreiro et al., 2006a) (P50.2835±
0.0060), between Afro-Brazilians and Zimbabweans (Boily-
Larouche et al., 2007) (P50.5503±0.0080) or sub-Saharan
Africans (Barreiro et al., 2007) (P50.5018±0.0071), and
between Brazilian Asians and Asians (Barreiro et al., 2006a)
(P51.0000±0.0000).
The presence of a significant association between SNPs was
estimated by a likelihood-ratio test of linkage disequilib-
rium considering all of the samples from the control
admixed and ethnic groups. A positive association was
detected between SNP 2336 and SNP 2201
(P50.0138±0.0005) and –139 (P50.0000±0.0000), and
between SNP 2332 and SNP 2139 (P50.0028±0.0002).
Given the positive association but unknown gametic phase,
the PHASE and EM algorithms were used to reconstruct
CD209 haplotypes (Table 2). The same haplotype was
estimated in all samples by the PHASE and EM algorithms,
with mean probabilities of 0.9753 and 0.9837, respectively.
HTLV-1 individuals
All HTLV-1 individuals were evaluated for clinical status.
Of these, 50% were HAC and 50% had HAM/TSP. None
of the patients showed positive serology for other retro-
viruses, e.g. human immunodeficiency virus type 1 (HIV-
1) or HTLV-2. The sex, age and ethnic background
distribution of the blood donors are shown in Table 3. The
HAM/TSP group showed a homogeneous distribution
between females and males. A high frequency of infection
among Caucasian individuals was detected in both the
HAC and HAM/TSP groups (Table 3).
Table 4 shows the genotype and allele frequencies for SNPs
2336, 2332, 2139 and 2201 among the HTLV-1-infected
individuals (HAC and HAM/TSP) and the admixed-
control group. It is important to note that the ethnic
background of the HTLV-1 groups, including HAC and
HAM/TSP, did not differ from that of the controls
(P50.1125±0.0079, P50.2812±0.0089 and P50.0916±
0.0062, respectively).
An exact test of population differentiation based on the
allele and genotype frequencies revealed that the total
HTLV-1 group showed differences in the allele (P50.0035)
and genotype (P50.0055) frequencies compared with the
controls. However, no differences were found between the
HAC and HAM/TSP groups. In order to detect a possible
influence of specific alleles or genotypes, 262 contingency
tables were created to compare the frequencies using
Fisher’s exact test.
The 2336A allele was found to be associated with
susceptibility to HTLV-1 infection and the 2336G allele
was found to be associated with protection against
infection when the HTLV-1-infected patients as a whole
were compared with the healthy-control group (P50.0197,
OR52.511, 95% CI51.218–5.179). Likewise, the 2336GG
genotype was found to be associated with protection
against HTLV-1 infection when the HTLV-1 group as a
whole was compared with the healthy-control group
(P50.0030, OR50.03759, 95% CI50.002008–0.7038).
On this basis, it is plausible to assume that the 2336G
allele is the variant conferring resistance to HTLV-1
infection. When the asymptomatic HTLV-1-infected
patients were compared with the HAM/TSP group, no
difference was found regarding this polymorphism
(P50.1353) (Table 4). However, the frequency of the
2336G allele was significantly lower in the asymptomatic
HTLV-1-infected group than in healthy controls
(P50.0036, OR50.2368, 95% CI50.0874–0.6414) (Table
4). Likewise, the frequencies of both homozygous geno-
types for the 2336 locus (AA and GG) in the asympto-
Table 2. CD209 haplotype frequencies in the Brazilian admixed population and among different ethnic groups
Haplotype Nucleotide at position Haplotype frequency
”336 ”332 ”201 ”139 Asians Caucasians African
descendants
Admixed
controls
Indians
H1 A G G G 0.3210 0.3889 0.3200 0.2969 0.7000
H2 G G G G 0.0540 0.2556 0.3600 0.2813 0.0000
H3 A G G A 0.5180 0.3000 0.2200 0.4063 0.3000
H4 G G T G 0.0000 0.0000 0.0600 0.0156 0.0000
H5 A A G A 0.1070 0.0444 0.0400 0.0000 0.0000
H6 G G G A 0.0000 0.0111 0.0000 0.0000 0.0000
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control group, the first one showing a higher frequency
(P50.0332, OR53.500, 95% CI51.134–10.806) and the
second one a lower frequency (P50.0244, OR50.07436,
95% CI50.003948–1.411) in patients (Table 4). Genotype
2336GG was also under-represented in the HAM/TSP
group compared with the healthy-control group
(P50.0244, OR50.07436, 95% CI50.003948–1.411)
(Table 4). Nevertheless, it is reasonable to infer that these
are probably hitchhiking effects of the protective influence
of the 2336G allele against HTLV-1 infection.
Regarding SNPs 2332 and 2201, no differences for the
allele and genotype frequencies were found among the
groups (Table 4). The 2139A allele was found to be
associated with protection against HTLV-1 infection
(P50.0037, OR50.3758, 95% CI50.1954–0.7229) when
the HTLV-1-infected patients as a whole were compared
with the healthy-control group. Likewise, the 2139AA
genotype was associated with protection against HTLV-1
infection (P50.0050, OR50.1116, 95% CI50.02168–
0.5745). No differences were found between the asympto-
matic group and the HAM/TSP group regarding this
polymorphism (P50.6666). However, the frequency of the
2139A allele was considerably lower in the asymptomatic
and HAM/TSP groups compared with the healthy-control
group (P50.0067, OR50.3248, 95% CI50.1459–0.7230
and P50.0377, OR50.4299, 95% CI50.2006–0.9209,
respectively) (Table 4). Likewise, the frequency of the
2139AA genotype was lower in the asymptomatic group
compared with the control (P50.0048, OR50.05075, 95%
CI50.002766–0.9310) (Table 4). However, these results
may also be a hitchhiking effect of the protective influence
of the 2139A allele against HTLV-1 infection.
An exact linkage-disequilibrium test taking into account all
samples revealed a high linkage disequilibrium between
SNPs 2336 and 2139 (P50.0000±0.0000), which may
indicate a possible additive or co-dependent effect for both
polymorphisms in the resistance/susceptibility to HTLV-1.
In order to determine such interactions, haplotypes for
each sample were estimated by two distinct methods
without taking into account any prior information. Table 5
shows the frequency of each haplotype found in HTLV-1-
infected patients and in the control group. An exact test of
differentiation based on haplotype frequencies revealed a
Table 3. Baseline characteristics of the Brazilian ethnic
population and individuals with HTLV-1
Characteristic Group
Control HAC HAM/TSP
n (total598) 32 33 33
Mean age (years)
[range]
34.8 [22–57] 40.5 [19–64] 53.2 [31–70]
Sex [%]
Male 27 [84.4] 15 [45.5] 10 [30.3]
Female 5 [15.6] 18 [54.5] 23 [69.7]
Ethnic background [%]
Non-white 11 [34.4] 5 [15.2] 7 [21.2]
Caucasian 20 [62.5] 25 [75.8] 26 [78.8]
Asian 0 [0] 1 [3.0] 0 [0]
Not determined 1 [3.1] 2 [6.0] 0 [0]
Table 4. Allele and genotype frequencies among HTLV-1-infected patients (HAC and HAM/TSP)
and a healthy-control group
Allele Genotype Controls (n532) HAM/TSP (n533) HAC (n533) HTLV-1 (n566)
2336 A 0.7031 0.8030 0.9091 0.8561
G 0.2969 0.1970 0.0909 0.1439
AA 0.5625 0.6061 0.8182 0.7121
AG 0.2813 0.3939 0.1818 0.2879
GG 0.1563 0.0000 0.0000 0.0000
2332 A 0.0000 0.0152 0.0455 0.0303
G 1.0000 0.9848 0.9545 0.9697
AA 0.0000 0.0000 0.0000 0.0000
AG 0.0000 0.0303 0.0909 0.0606
GG 1.0000 0.9697 0.9091 0.9394
2201 T 0.0156 0.0455 0.0303 0.0379
G 0.9844 0.9545 0.9697 0.9621
TT 0.0000 0.0000 0.0000 0.0000
TG 0.0313 0.0909 0.0606 0.0758
GG 0.9688 0.9091 0.9394 0.9242
2139 A 0.4063 0.2273 0.1818 0.2045
G 0.5938 0.7727 0.8182 0.7955
AA 0.2188 0.0606 0.0000 0.0303
AG 0.3750 0.3333 0.3636 0.3485
GG 0.4063 0.6061 0.6364 0.6212
DC-SIGN (CD209) polymorphisms in HTLV-1 infection
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healthy-control group (P50.0000±0.0000). As observed
for the allele and genotype frequencies, there was no
difference between the HAM/TSP and the asymptomatic
group (P50.3328±0.0206), but both HTLV-1 groups did
differ from the healthy-control group (P50.0005±0.0004
and P50.0000±0.0000, respectively).
In fact, when the HTLV-1 group as a whole was compared
with the healthy-control group, haplotypes 2336G/
2332G/2201G/2139G and 2336A/2332G/2201G/
2139A were found to be associated with protection against
HTLV-1 infection (P50.0045, OR50.3276, 95%
CI50.1524–0.7045 and P50.0015, OR50.3248, 95%
CI50.1667–0.6327, respectively), whilst haplotype
2336A/2332G/2201G/2139G was associated with sus-
ceptibility to HTLV-1 infection (P,0.0001, OR54.145,
95% CI52.179–7.884). It is noteworthy that both
haplotypes conferring protection carried a single dose of
a protective allele (2336G or 2139A), as well as a single
dose of a susceptibility allele (2336A and 2139G), whilst
the susceptibility haplotype carried a double dose of the
susceptibility alleles (2336A and 2139G) (Table 5). In
addition, following the same pattern of allele/genotype
distribution among the groups, no difference was found
between the HAM/TSP and asymptomatic groups
(Table 5).
DISCUSSION
We have described here for the first time the distribution of
genetic polymorphisms in the CD209 gene promoter
(2336A/G, 2332A/G, 2201T/G and 2139A/G positions)
in distinct Brazilian ethnic groups and also their asso-
ciation with HTLV-1 infection.
In the Brazilian population studied here, the 2336G allele
was more frequent in the Afro-Brazilian group than in the
Caucasian and Asian groups. However, the GG genotype
was not detected in the Asian group and most subjects
(86%) were AA homozygotes, with only 13% being
heterozygotes. These data agree with previous studies that
reported a higher frequency of the 2336G allele in
populations of African descent (Barreiro et al., 2006a;
Boily-Larouche et al., 2007; Olesen et al., 2007).
An interesting result was the identification of the 2332A
allele at high frequency in the Asian group (10.7%). This
variant has recently been described by Boily-Larouche et al.
(2007) in a Zimbabwean population (2%) as a probable
position that can influence gene transcription.
The 2201T allele was exclusively detected in the Afro-Brazilian
population and has been reported only in African ethnic
groups (Boily-Larouche et al., 2007). This SNP was also
observed here in the control group, demonstrating that, despite
the miscegenation of the Brazilian population, the methodo-
logy used was efficient in separating the ethnic groups.
A high prevalence of the 2139A allele was observed in the
Asian population compared with the other ethnic groups.
A similar result has been reported previously by Barreiro et
al. (2006a) in a study assessing the frequency of this
polymorphism in individuals of African, Asian and
European descent. However, we have reported here for
the first time the distribution of the 2129G allele among
Amerindians, which was surprisingly high (70.3%).
As recently demonstrated, DCs play an important role in
HTLV-1 infection, promoting contagion of T cells in both
the cis and trans forms (Jones et al., 2008). According to
previous findings, HTLV-1-infected cells can use surface-
adhesion molecules to regulate fusion with target cells, with
the involvement of DC-SIGN and ICAM ligands. This
mechanism could have consequences for the regulation of
both DC infection and HTLV-1 dissemination, but also for
immune regulation (Ceccaldi et al., 2006). On this basis, in
the present study we assessed SNP distribution in the
promoter region of the CD209 gene in an attempt to
associate these polymorphisms with HTLV-1 infection.
Infected individuals were divided into asymptomatic
carriers and HAM/TSP carriers according to clinical
condition, and the distribution of the polymorphisms
was analysed in each group.
Regarding SNP 2336, allele G was found to be less
frequent among HAM/TSP (20%) than HAC (9%)
individuals compared with controls (30%). The absence
of the GG genotype in the HTLV-1-infected group suggests
that this 2336G allele is a variant that confers protection
against HTLV-1 infection. Thus, the presence of the
2336G allele would result in lower DC susceptibility to
Table 5. CD209 haplotype frequencies among HTLV-infected patients and controls
Haplotype Nucleotide at position Haplotype frequency
”336 ”332 ”201 ”139 HAM/TSP HAC CTRL HTLV-1
H1 A G G G 0.5757 0.6969 0.2969 0.6363
H2 G G G G 0.1515 0.0757 0.2812 0.1136
H3 A G G A 0.2121 0.1515 0.4062 0.1818
H4 G G T G 0.0454 0.0151 0.0156 0.0303
H5 A A G A 0.0151 0.0303 0.0000 0.0227
H6 A A G G 0.0000 0.0151 0.0000 0.0075
H7 A G T G 0.0000 0.0151 0.0000 0.0075
S. Kashima and others
932 Journal of General Virology 90HTLV-1 in the initial stages of infection, possibly
protecting against HTLV-1 infectivity.
In agreement with the present results, the 2336G allele has
been associated with reduced DC-SIGN expression on the
DC surface and in macrophages, as position 2336 is
located close to the major transcription site, possibly
affecting binding of the transcription factor Sp1 and other
factors that modulate transcriptional activity (Sakuntabhai
et al., 2005). On this basis, the antigen-presenting capacity
of individuals who carry the 2336G allele would be
impaired, with a consequent alteration of the immune
response. Regarding infectious diseases, position 2336 in
the promoter region of the CD209 gene has been studied
extensively. Vannberg et al. (2008) demonstrated that allele
2336G is associated with protection against tuberculosis in
the population of sub-Saharan Africa. Conversely, the
2336G variant has been associated with susceptibility to
HIV infection, haemorrhagic dengue and tuberculosis,
suggesting that high levels of DC-SIGN expression permit
better capture and processing of the antigens (Barreiro
et al., 2006a; Martin et al., 2004; Sakuntabhai et al., 2005).
Similarly, in the present study, polymorphisms at positions
2332 and 2201 of the promoter region of CD209 were
investigated and no significant association was found when
the genotypes and alleles of infected individuals were
compared with those of controls or when the HAC and
HAM/TSP groups were compared.
For the SNP at position 2139, allele A was found to be
associated with protection against HTLV-1 infection when
the infected and control groups were compared. Thus, these
resultssuggestthat thisSNPmay be associated withHTLV-1
transmission and not with development of the associated
clinical manifestations. Previous studies have already
demonstrated a higher frequency of allele 2139A in
individuals not infected with HIV compared with infected
patients (Martin et al., 2004). In anotherstudy,allele 2139G
was found to be associated with rapid progression of AIDS
in a population of Japanese haemophiliacs. This SNP is
located close to one of the binding sites of the transcription
factor AP-1 in the promoter region of DC-SIGN and the
substitution of one nucleotide close to this site can increase
the level of expression of DC-SIGN, resulting in an
accelerated progression of AIDS (Koizumi et al., 2007).
Comparison of the HTLV-1 group and the healthy-control
group showed that haplotypes 2336G/2332G/2201G/
2139G and 2336A/2332G/2201G/2139A were asso-
ciated with protection against HTLV-1 infection, whilst
haplotype 2336A/2332G/2201G/2139G was associated
with susceptibility to HTLV-1 infection. These associations
suggest that these polymorphisms may influence only the
acquisition of HTLV-1 and not the associated diseases.
Comparison of the HAM/TSP and asymptomatic groups
with healthy controls revealed the presence of the same
haplotypes conferring protection and susceptibility against
HTLV-1, suggesting that these polymorphisms also have a
hitchhiking effect on HTLV-1 acquisition.
In conclusion, the variations detected in the promoter
region of the CD209 gene may not be involved directly in
triggering the development of HAM/TSP. However, the
differences in SNP distribution observed between HTLV-1-
infected individuals and controls suggest that these SNPs in
the promoter region of CD209 may be associated with the
risk of HTLV-1 infection. Thus, the variations observed at
positions 2336 and 2139 in the lectin DC-SIGN may be of
crucial importance in the susceptibility/transmission of
HTLV-1 infection.
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